2021 annual financial data
TG Therapeutics 2021 Operating margin
Direct answer
Operating margin was -5,154.28%.
Operating income was -344,770,000 USD and net income was -348,101,000 USD.
Operating cash flow was -295,634,000 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,689,000 USD
- Operating income
- -344,770,000 USD
- Net income
- -348,101,000 USD
- Operating cash flow
- -295,634,000 USD